Muscular dystrophy

899,314views

Muscular dystrophy

MSK Module Content

MSK Module Content

Resting membrane potential
Action potentials in myocytes
Neuron action potential
Neuromuscular junction and motor unit
Sliding filament model of muscle contraction
Cholinergic receptors
Lambert-Eaton myasthenic syndrome
Neuromuscular junction disorders: Pathology review
Myasthenia gravis
Myalgias and myositis: Pathology review
Pediatric orthopedic conditions: Clinical
Muscle weakness: Clinical
Slow twitch and fast twitch muscle fibers
Muscle spindles and golgi tendon organs
Muscle contraction
Skeletal muscle histology
Muscular system anatomy and physiology
Lower back pain: Clinical
Back pain: Pathology review
Systemic lupus erythematosus (SLE): Clinical
Osteoporosis
Child abuse: Clinical
Non-steroidal anti-inflammatory drugs
Rheumatoid arthritis
Physiological changes during exercise
Polymyositis
Lordosis, kyphosis, and scoliosis
Spinal disc herniation
Acetaminophen (Paracetamol)
Osteochondroma
Scleroderma
Skeletal system anatomy and physiology
Bone remodeling and repair
Legg-Calve-Perthes disease
Genu varum
Inflammatory myopathies: Clinical
Muscular dystrophies and mitochondrial myopathies: Pathology review
Mitochondrial myopathy
Inclusion body myopathy
Monoclonal antibodies
Spondylolysis
Spondylosis
Spondylitis
Bone disorders: Pathology review
Muscular dystrophy
Mixed connective tissue disease
Cartilage histology
Raynaud phenomenon
Scleroderma: Pathology review
Osteoarthritis
Cartilage structure and growth
Fibrous, cartilage, and synovial joints
Septic arthritis
Slipped capital femoral epiphysis
Bone tumors
Osgood-Schlatter disease (traction apophysitis)
Achondroplasia
Rheumatoid arthritis: Clinical
Developmental dysplasia of the hip
Bone tumors: Pathology review
Neck trauma: Clinical
Spinal cord reflexes
Pediatric bone and joint infections: Clinical
Paget disease of bone
Bone histology
Pediatric bone tumors: Clinical
Anatomy clinical correlates: Bones, joints and muscles of the back
Joints of the wrist and hand
Osteomalacia and rickets
Osteomalacia
Osteopetrosis
Osteoporosis medications
Osteosclerosis
Osteogenesis imperfecta
Osteomyelitis
Clostridium perfringens
Necrotizing fasciitis
Skin and soft tissue infections: Clinical
Brachial plexus
Anatomy of the brachial plexus
Klumpke paralysis
Anatomy clinical correlates: Wrist and hand
Muscles of the hand
Achilles tendon rupture
Rotator cuff tear
Somatosensory receptors
Carpal tunnel syndrome
Patellar tendon rupture
Ankylosing spondylitis
Marfan syndrome
Polymyalgia rheumatica
Reactive arthritis
Seronegative arthritis: Clinical
Psoriatic arthritis
Juvenile idiopathic arthritis
Seronegative and septic arthritis: Pathology review
Rheumatoid arthritis and osteoarthritis: Pathology review
Ehlers-Danlos syndrome
Alport syndrome
Gout
Gout and pseudogout: Pathology review
Antigout medications
Nucleotide metabolism
Joint pain: Clinical
Lesch-Nyhan syndrome
Thoracic outlet syndrome
Introduction to the muscular system
Introduction to the skeletal system
Development of the muscular system
Torticollis
Pigeon toe
Neuromuscular blockers
Myotonic dystrophy
Development of the axial skeleton
Development of the limbs
Muscles of the back
Anatomy of the arm
Anatomy clinical correlates: Clavicle and shoulder

Transcript

Watch video only

Content Reviewers

With muscular dystrophy, “dys” means bad or difficult, and “troph” means nourish; so muscular dystrophy basically refers to the muscle appearing poorly nourished because of degeneration, which leads to muscle weakness.

Under a microscope, a biopsy of the tissue shows changes in the muscle itself but not in the nerve or neuromuscular junction; this distinguishes muscular dystrophy from other problems that cause muscle weakness as a result of nerve damage, like neuropathies.

Muscular dystrophy is actually a group of disorders, all of which are caused by genetic mutations.

Within that group, dystrophinopathies are the most common, which includes Duchenne muscular dystrophy, or DMD, and Becker muscular dystrophy, both of which result from mutations in the dystrophin gene.

In addition to those two, genetic mutations in other genes are responsible for several dozen other muscular dystrophies, some of which code for proteins that form a protein complex with dystrophin protein.

These other muscular dystrophies, therefore end up causing a lot of the same symptoms as the dystrophinopathies.

Now, the fact that both Duchenne and Becker muscular dystrophy result from mutations in the same dystrophin gene means that they are “allelic disorders,” and when a mutation occurs in dystrophin that’s severe enough to result in no protein at all, for example a nonsense or a frameshift mutation, the result is Duchenne muscular dystrophy, which ends up being the more severe of the two, with symptoms usually presenting by age 5.

On the other hand, mutations that allow for a misshapen protein to form, like missense mutations, lead to Becker muscular dystrophy which is basically a milder form of Duchenne muscular dystrophy that presents later on, usually between age 10 to 20.

Alright so the dystrophin gene is a huge gene on the X-chromosome, that has 79 exons and is over 2 million base pairs in length.

By comparison, most genes have only about 10 exons and are 50 thousand base pairs in length.

More base pairs and more exons mean that there are more chances for mistakes during meiosis, which is when the egg or sperm are being created.

Most of these gene mutations are deletions or duplications of one or more exons, and a small amount are point mutations.

Now males males have one X and one Y chromosome, and females have two X chromosomes.

This means it’s way more common in boys, because they only have one copy of the dystrophin gene, and if that copy’s defective, it’s the only one available to muscle cells, whereas girls with a defective dystrophin gene might have another functional one.

Since this is linked to the X chromosome, both Duchenne and Becker muscular dystrophy are called X-linked recessive.

In females, though, only one X chromosome gets expressed, and the other is inactivated, called X-inactivation or lyonization.

Now if this inactivation’s random, you’d expect about half of the female’s cells to have a functional dystrophin gene and the other half to have a defective dystrophin gene, and these people are typically asymptomatic.

Having said that, if more cells end up with the defective dystrophin gene, and less with the functional one, they can end up being “manifesting carriers,” meaning that they manifest or show some symptoms.

Key Takeaways

Muscular dystrophy is a group of inherited diseases that cause progressive weakness and degeneration of the skeletal muscles that control movement (e.g. Duchenne and Becker muscular dystrophy). Muscular dystrophy is caused by genetic defects that interfere with the production of proteins needed to form healthy muscle. There is currently no cure for muscular dystrophy, physical and occupational therapy, and medications can help manage the symptoms and slow the progression of the disease.